Yagi Kenji, Hijikata Yasukazu, Tao Yoshifumi, Sunada Yoshihiro, Haruta Ryunosuke, Maruno Masato, Minami Yukari, Edaki Hisanori, Hirai Satoshi, Inoue Satoshi, Hishikawa Tomohito, Uno Masaaki
Department of Neurosurgery, Kawasaki Medical School, Kurashiki.
Section of Clinical Epidemiology, Department of Community Medicine, Kyoto University.
Neurol Med Chir (Tokyo). 2025 Apr 15;65(4):195-202. doi: 10.2176/jns-nmc.2024-0308. Epub 2025 Mar 21.
Bilateral chronic subdural hematoma is treated by burr-hole surgery. Patients may undergo simultaneous bilateral surgery, or unilateral surgery which occasionally necessitates subsequent contralateral surgery due to the contralateral chronic subdural hematoma progression. Contralateral chronic subdural hematoma progression is not well understood, and an optimal surgical strategy for bilateral chronic subdural hematoma remains undefined. This study aimed to identify predictors for contralateral chronic subdural hematoma progression following unilateral surgery in patients with bilateral chronic subdural hematoma, specifically examining contralateral chronic subdural hematoma presented as membranous (indicating an older hematoma) and the contralateral hematoma volume. In this prospective observational study, 39 patients with bilateral chronic subdural hematoma requiring surgery were included between February 2020 and July 2024. All patients initially underwent unilateral burr-hole surgery. Additional surgery was performed if contralateral chronic subdural hematoma progression occurred. The preoperative predictors of contralateral chronic subdural hematoma progression were investigated. Among the 39 patients, 16 (41%) experienced contralateral chronic subdural hematoma progression, necessitating contralateral surgery. Of the 12 patients with membranous-type chronic subdural hematoma on the contralateral side, contralateral chronic subdural hematoma progression developed in one patient (8%), whereas 15 (56%) of the 27 patients with non-membranous type had contralateral chronic subdural hematoma progression. Logistic regression analyses revealed that membranous-type hematoma was negatively associated with the risk of contralateral chronic subdural hematoma progression, with an odds ratio of 0.07 (95% confidence interval: 0.01-0.65). Additionally, preoperative hematoma volume on the contralateral side was identified as a risk factor for contralateral chronic subdural hematoma progression, with an odds ratio of 1.58 (95% confidence interval: 1.04-2.40) per 10 mL increase. The membranous type and small volume of contralateral chronic subdural hematoma were associated with a lower risk of contralateral chronic subdural hematoma progression after unilateral surgery in bilateral chronic subdural hematoma. We suggest applying unilateral surgery selectively to bilateral chronic subdural hematoma with these characteristics.
双侧慢性硬膜下血肿采用钻孔手术治疗。患者可同时进行双侧手术,或进行单侧手术,由于对侧慢性硬膜下血肿进展,单侧手术偶尔需要后续进行对侧手术。对侧慢性硬膜下血肿进展的情况尚未完全了解,双侧慢性硬膜下血肿的最佳手术策略仍不明确。本研究旨在确定双侧慢性硬膜下血肿患者单侧手术后对侧慢性硬膜下血肿进展的预测因素,特别研究表现为膜性(提示血肿较陈旧)的对侧慢性硬膜下血肿和对侧血肿体积。在这项前瞻性观察研究中,纳入了2020年2月至2024年7月期间39例需要手术的双侧慢性硬膜下血肿患者。所有患者最初均接受单侧钻孔手术。如果发生对侧慢性硬膜下血肿进展,则进行额外手术。研究了对侧慢性硬膜下血肿进展的术前预测因素。在这39例患者中,16例(41%)出现对侧慢性硬膜下血肿进展,需要进行对侧手术。在对侧为膜性型慢性硬膜下血肿的12例患者中,1例(8%)出现对侧慢性硬膜下血肿进展,而在27例非膜性型患者中,15例(56%)出现对侧慢性硬膜下血肿进展。逻辑回归分析显示,膜性型血肿与对侧慢性硬膜下血肿进展风险呈负相关,比值比为0.07(95%置信区间:0.01-0.65)。此外,术前对侧血肿体积被确定为对侧慢性硬膜下血肿进展的危险因素,每增加10 mL,比值比为1.58(95%置信区间:1.04-2.40)。双侧慢性硬膜下血肿单侧手术后,对侧慢性硬膜下血肿的膜性型和小体积与对侧慢性硬膜下血肿进展风险较低相关。我们建议对具有这些特征的双侧慢性硬膜下血肿选择性地应用单侧手术。